دورية أكاديمية

Complete Response to Sequential Human Epidermal Growth Factor Receptor 2-Targeted Strategies in a Heavily Pretreated Patient With Human Epidermal Growth Factor Receptor 2-Amplified Metastatic Bladder Cancer.

التفاصيل البيبلوغرافية
العنوان: Complete Response to Sequential Human Epidermal Growth Factor Receptor 2-Targeted Strategies in a Heavily Pretreated Patient With Human Epidermal Growth Factor Receptor 2-Amplified Metastatic Bladder Cancer.
المؤلفون: Lima NF Jr; Hospital Sírio-Libanês, São Paulo, Brazil., Sampaio LAF; Hospital Sírio-Libanês, São Paulo, Brazil., Xavier CB; Hospital Sírio-Libanês, São Paulo, Brazil., Mattedi RL; Hospital Sírio-Libanês, São Paulo, Brazil., Queiroz MA; Hospital Sírio-Libanês, São Paulo, Brazil., Nahas WC; Hospital Sírio-Libanês, São Paulo, Brazil.; Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil., Jardim DL; Hospital Sírio-Libanês, São Paulo, Brazil.; Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil.
المصدر: JCO precision oncology [JCO Precis Oncol] 2023 Jan; Vol. 7, pp. e2200414.
نوع المنشور: Case Reports; Journal Article
اللغة: English
بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Alexandria, VA : American Society of Clinical Oncology, [2017]-
مواضيع طبية MeSH: Receptor, ErbB-2*/metabolism , Urinary Bladder Neoplasms*/drug therapy , Urinary Bladder Neoplasms*/genetics, Humans
المشرفين على المادة: EC 2.7.10.1 (ERBB2 protein, human)
EC 2.7.10.1 (Receptor, ErbB-2)
تواريخ الأحداث: Date Created: 20230109 Date Completed: 20230112 Latest Revision: 20230223
رمز التحديث: 20231215
DOI: 10.1200/PO.22.00414
PMID: 36623240
قاعدة البيانات: MEDLINE
الوصف
تدمد:2473-4284
DOI:10.1200/PO.22.00414